Sat Kartar Life Limited · NSE:SATKARTAR
Sat Kartar Life — H1 FY27 Earnings Presentation
42 slides from Sat Kartar Life's earnings presentation, Oct 25, 2026
Slide 1: Sat Kartar Life Limited - Regulation 30 Intimation
SAT KARTAR LIFE LIMITED (Formerly known as Sat Kartar Shopping Limited) Dated: 25.10.2026 To, The Manager- Listing Compliance National Stock Exchange India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla complex, Bandra (E), Mumbai 400051 SYMBOL: SATKARTAR ISIN: INE0NB801022 Sub: Intimat
Slide 2: Investor Presentation - H1 FY27
Investor Presentation - H1 FY27 Stronger Brands. Healthier Tomorrows.
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sat Kartar Life Limited (the“Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securit
Slide 4: Company Overview
Company Overview
Slide 5: An Integrated Ayurveda & Wellness Platform
An Integrated Ayurveda & Wellness Platform KEY METRICS KEY HIGHLIGHTS 5 Lacs+ In-house & Contract manufacturing Customers Served Ayurvedic Solutions Across - Chronic Care, Pain 9+ Million Management, Digestive, Respiratory & Wellness Annual Customer Inquiries Licensed Formulations Developed 160+ SKU
Slide 6: Our Business at Glance
Our Business at Glance Building an Integrated Ayurveda Healthcare Platform • Founded in 2012, Sat Kartar began its journey with a focus on Ayurvedic healthcare and wellness products. • Over the years, the Company scaled to 160+ SKUs, building a pan-India D2C presence. • In FY26, Sat Kartar expanded
Slide 7: Key Milestones
Key Milestones A journey that keeps growing 2025 2018 Raised ₹33.8 Crores and 2012 Entered digital marketing listed on NSE Emerge on Incorporated & launched 17 January 2025 first product Investor Presentation - H1 FY27 2026 2022 2014 Surpassed ₹50 Crores Entered healthcare services with the launch o
Slide 8: Business Model: Integrated Ayurvedic Wellness
Business Model: Integrated Ayurvedic Wellness REVENUE STREAMS Product Sales Services Ayurvedic & Wellness Products Hospital & Treatment Services 160+ 30 Beds ~300 Beds SKUs Already operational Targeted by end of FY27 D2C Retail Online Distribution Consultations Therapies Hospitalisation PRODUCT TO P
Slide 9: From Formulation to Patient Care
From Formulation to Patient Care 06 05 04 Patient Treatment 03 Product Launch & 02 In-house + Sales Ayurvedic solutions 01 Internal Approval AYUSH Ministry Contract Manufacturing Products brought to market through our deliver better health and wellness sales network Formulation Licensed Formulations
Slide 10: Treatment Areas Across Our Brands
Treatment Areas Across Our Brands AVERAGE SELLING PRICE RANGE Vedabay Plantomed Sat Kartar Life ₹800 – ₹1,000 ₹1,200 – ₹1,500 ₹3,200 – ₹3,300 ₹0 ₹500 ₹1,000 ₹1,500 ₹2,000 ₹2,500 ₹3,000 ₹3,500 VEDABAY PLANTOMED SAT KARTAR LIFE Wellness & nutritional support Condition-focused Ayurvedic care Broad-base
Slide 11: Product Portfolio
Product Portfolio Sat Kartar Condition-specific Ayurvedic therapeutics Liver Care Addiction Killer Ortho Veda Oil Dr. Piles Free Saumya Plus Nasha Free Aadved Ayush 82 Kaama Gold Fatty Liver Addiction Joint & Bone Piles Vitiligo De-addiction Diabetes Men's Vitality Vedabay Wellness, nutrition and li
Slide 12: Bifurcation Between Treatment Areas
Bifurcation Between Treatment Areas 80% Revenue contribution Top 5 treatment areas Sexual Wellness Diabetes Piles Care De-Addictions Bone & Joints 20% Revenue contribution Other 9 treatment areas Investor Presentation - H1 FY27 PCOS Respiratory Hair Liver Infertility Mind Immune Lungs Personal PCOD
Slide 13: Scaling Ayurvedic Healthcare Infrastructure
Scaling Ayurvedic Healthcare Infrastructure Key Highlights ~ 4k-10k sq ft Area per hospital ₹5-6 lacs More Cost per bed Hospitals. Greater ~ 10-30 beds Impact. Per hospital Healing Through Nature ~ 300 Beds Targeted by the end of FY27 Investor Presentation - H1 FY27 Data-Led Site Selection Property
Slide 14: Debt-Free, Cash-Fast Business Model
Debt-Free, Cash-Fast Business Model Growth funded by operations, not by lenders HOW CASH IS REALISED BALANCE SHEET · SEP-26 Product Sales NET Prepaid orders Encashed at checkout T+0 D2C-led · 160+ SKUs DEBT-FREE COD ORDERS T + 7–10 days ₹18.7 Crs Order placed Shipped via courier Delivered · cash col
Slide 15: The Power of an Asset-Light Healthcare Model
The Power of an Asset-Light Healthcare Model Lean Infrastructure Scale Through A Connected Care All This Will Result in Opening Hospitals Network • Setup cost of ₹5-6 lakh • Company-led investment • ~9 million annual inquiries, per bed (typical 10-30 bed in hospital infrastructure driven by a strong
Slide 16: Healthtech-Led Engagement at Scale
Healthtech-Led Engagement at Scale 1600+ Strong workforce Each figure represents 100 team members 7 LANGUAGES 30+ Mn “ Hindi Kannada Tamil Telugu A team that speaks wellness in Consumer database Bengali English Malayalam every vernacular language. we leverage PAN-India End-to-end Local cultural cove
Slide 17: Pan-India Footprint, Targeted Growth
Pan-India Footprint, Targeted Growth North India : 42.4% We ensure availability of our South India : 57.6% products all over India South India is a key growth market, led by Tamil Nadu’s contribution We serve to more than 12,000+ Pincodes across India Top Revenue Contributing States: Our marketing c
Slide 18: Product Quality & Certifications
Product Quality & Certifications CERTIFICATIONS SINCE All products manufactured in GMP-certified GMP Certified 2012 facilities High standard & international quality assurance ISO Certified of ISO Made in India Products with Indian roots, manufactured in India Sat Kartar Life Limited is a trusted lea
Slide 19: Leadership Profile
Leadership Profile Three decades of finance and operating leadership 2012 30+ CA B.Com Founded Sat Kartar Years of experience Qualified, ICAI (Hons), University of Life (1994) Delhi (1990) PROFESSIONAL JOURNEY Financial Business Support Chief Financial Chief Financial Founder Controller Head Officer
Slide 20: Leadership Team
Leadership Team Ved Prakash Pranav Singh Chadha Decades of leadership Managing Director Executive Director experience 16+ Yrs 8+ Yrs He holds a Bachelor’s degree in Commerce from the He holds a degree in Commerce from Sri Guru Gobind University of Delhi and brings over 16 years of expertise Singh Co
Slide 21: Clinical Expertise Rooted in Ayurveda
Clinical Expertise Rooted in Ayurveda Dr. Ravinder Dr. Hindika Dr. Mansi Kaur Bhagat Decades of combined clinical experience 23+ yrs exp. 8+ yrs exp. 6+ yrs exp. SPECIALISATION SPECIALISATION SPECIALISATION Kidney Disease, Liver Disorder, Joints Pain, Infertility Counselor, Sexual Health, Men’s Join
Slide 22: Industry Overview
Industry Overview
Slide 23: Healthcare Backdrop
Healthcare Backdrop Global Backdrop India Healthcare US$ Bn 9–10% CAGR US$ 202.5 Bn US$ 12.5 Tn 610 India hospital market by 2030E global healthcare market, 2026E 10.6% CAGR ~8–9% CAGR 430 The shift Consumers increasingly favour preventive US$ 8 Tn and personalised care: nutrition, natural supplemen
Slide 24: Ayurveda Market Outlook
Ayurveda Market Outlook Global Ayurveda Market (US$ Bn) 78.6% 19.7% CAGR 2025 20.4 Asia Pacific share of global Ayurveda market, 2025 2026E 24.3 4.2x scale-up by 2033E 2033E 85.8 What's driving demand Preventive health & lifestyle-disorder awareness India Ayurvedic Products (₹ Lakh Cr) 15.5% CAGR Pr
Slide 25: India's Ayush Opportunity
India’s Ayush Opportunity Ayush Services Economy Growth Runway to 2047 ~6–9x potential India · FY2024-25 · RIS–Ministry of Ayush study US$ 36.9 Bn US$ 216–318 Bn 16.9% CAGR since FY23 US$ 36.9 Bn FY25 Potential size by 2047 Backed by Ministry of Ayush support for research, quality standardisation an
Slide 26: Industry Overview
Industry Overview Medical Value Travel (MVT) How these tailwinds translate for Sat Kartar India (US$ Bn) 13% CAGR Preventive healthcare shift 2025 8.7 Long-term Ayurvedic management of chronic lifestyle conditions 2030E 16.2 Digital adoption Global (US$ Bn) 10.8% CAGR AI-enabled engagement, multilin
Slide 27: Strategic Overview
Strategic Overview
Slide 28: Capital Raise & Ecosystem Synergy
Capital Raise & Ecosystem Synergy Equity shares & Hospital Expansion warrants LOIs Issued at ₹172 per share Capital Broaden our range of Raise to fuel growth & integration. healthcare offerings. FUELING EXPANSION AND LONG-TERM ₹47.22 Cr VALUE CREATION A stronger financial total capital foundation Ra
Slide 29: Aligning Core Strengths with Industry Tailwinds
Aligning Core Strengths with Industry Tailwinds Industry tailwind How Sat Kartar is placed 01 Long-term Ayurvedic Trusted Formulations Shift to preventive management of lifestyle Doctor-formulated AYUSH, GMP & ISO compliant & chronic care conditions Chronic & lifestyle range 02 Tele-consultation, ca
Slide 30: Strengthen, Scale, and Expand
Strengthen, Scale, and Expand OUR DESTINATION An Integrated Ayurveda Healthcare Ecosystem VedaBay US range Strengthen the core Build the care ecosystem Widen the map Hyper-personalised wellness New everyday categories AI matches advice and products to Scale the hospital network VedaBay nutraceutical
Slide 31: Half Yearly Financials
Half Yearly Financials
Slide 32: H1 FY27 - Snapshot
H1 FY27 - Snapshot Revenue EBITDA PAT EBITDA Margin +26.4% +47.7% +26.7% 113.9 9.2 12.7% 14.5 +180 bps 90.1 7.3 9.8 PAT Margin 8.1% Investor Presentation - H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 All Figures in INR Crs. 31
Slide 33: Income Statement
Income Statement Particulars H1 FY27 H1 FY26 Y-o-Y H2 FY26 H-o-H Revenue from Operations 113.9 90.1 26.4% 110.6 2.9% Purchase of Stock-In-Trade 9.3 7.2 12.9 Changes in Inventories of Stock-In-Trade -0.6 -1.8 -3.8 Gross Profit 105.1 84.7 24.2% 101.6 3.5% Gross Profit Margin (%) 92.3% 94.0% -170 bps 9
Slide 34: Balance Sheet
Balance Sheet Particulars Sep-26 Mar-26 Particulars Sep-26 Mar-26 Assets Equity and liabilities Non-current assets Share capital 15.7 15.7 Reserves and surplus 59.7 51.9 Property, Plant and Equipment 13.9 12.0 Money received against share warrants 11.6 - Non-current investments 0.5 0.5 Total equity
Slide 35: Cash Flow Statement
Cash Flow Statement Particulars Sep-26 Mar-26 Cash Flow from Operating Activities Profit before Tax 12.3 23.2 Adjustment for Non-Operating Items 2.2 1.7 Operating Profit before Working Capital Changes 14.6 24.9 Changes in Working Capital -19.0 -18.2 Cash Generated/Used from Operations -4.4 6.7 Less:
Slide 36: Historical Financials
Historical Financials vé
Slide 37: Key Financial Metrics
Key Financial Metrics Revenue EBITDA PAT 200.7 24.7 17.1 162.9 127.9 14.2 14.5 113.9 9.8 9.2 10.2 6.3 FY 24 FY 25 FY 26 H1 FY27 FY 24 FY 25 FY 26 H1 FY27 FY 24 FY 25 FY 26 H1 FY27 All Figures in INR Crs. ROE ROCE Working Capital Days 91.5% 113 Investor Presentation - H1 FY27 66.8% 99 98 25.3% 25.6%
Slide 38: Historical Income Statement
Historical Income Statement Particulars FY24 FY25 FY26 H1 FY27 Revenue from Operations 127.9 162.9 200.7 113.9 Purchase of Stock-In-Trade 9.3 13.0 20.1 9.3 Changes in Inventories of Stock-In-Trade -0.3 -4.0 -5.6 -0.6 Gross Profit 118.9 153.9 186.2 105.1 Gross Profit Margin (%) 93% 94.5% 92.8% 92.3%
Slide 39: Historical Balance Sheet
Historical Balance Sheet Particulars Mar 24 Mar 25 Mar 26 Sep 26 Particulars Mar 24 Mar 25 Mar 26 Sep 26 Assets Equity and liabilities Non-current assets Share capital 2.8 15.7 15.7 15.7 Property, Plant and Equipment 2.7 6.2 12.0 13.9 Reserves and surplus 6.6 35.8 51.9 59.7 Non-current investments 1
Slide 40: Historical Cash Flow Statement
Historical Cash Flow Statement Particulars Mar 24 Mar 25 Mar 26 Sep 26 Cash Flow from Operating Activities Profit before Tax 8.6 13.2 23.2 12.3 Adjustment for Non-Operating Items 2.0 2.2 1.7 2.2 Operating Profit before Working Capital Changes 10.6 15.3 24.9 14.6 Changes in Working Capital -0.6 -17.1
Slide 41: Growth Outlook
Growth Outlook ~3–5 Hospitals / month AVERAGE ROLLOUT PACE 30 Operational Beds ~10–30 beds / hospital 300 TARGET FACILITY SIZE Targeted Beds By FY27 Today ₹5–6 lakh High ~1000 beds UNIT ECONOMICS Targeted Utilisation Average Cost Per Bed Targeted Beds By FY28 Of Operational Beds BU SINESS TRANSFORM
Slide 42: Thank You
Thank You Company Investor Relations Partner Sat Kartar Life Ltd X-B4 Advisory LLP Gautam Kothari / Gautam Sipani CIN: L52590DL2012PLC238241 Tel: +91 79776 16640 / +91 90821 98752 Email ID: [email protected] Email ID: [email protected] / Tel: +011-40550741 [email protected] Website: www.satkartar.